Outcomes of Selective Laser Trabeculoplasty as Primary Treatment for Ocular Hypertension and Mild Open Angle Glaucoma in the Saudi Arabian Population

Authors

  • Nawaf Almarzouki Department of Ophthalmology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

DOI:

https://doi.org/10.22317/jcms.v10i6.1656

Keywords:

selective laser trabeculoplasty (SLT), ocular hypertension, glaucoma, intraocular pressure, Saudi Arabia

Abstract

Background: Selective laser trabeculoplasty (SLT) is a promising, minimally invasive, non-surgical procedure for lowering IOP in glaucoma patients. While various studies have established the efficacy of SLT in lowering IOP in glaucoma patients there are limited data on its outcomes as a primary treatment modality in the Saudi Arabian population. That’s why it is essential to understand the effectiveness of therapeutic interventions in specific populations to optimize treatment strategies.

Methods:. A retrospective cohort design was used.  54 eyes of patients with ocular hypertension (OHT) or mild primary open-angle glaucoma (POAG) underwent SLT. IOP, medication use, and potential influencing factors were monitored over one year.

Results: SLT significantly reduced IOP (p < 0.001 for all comparisons). The mean IOP decreased from 20.57 mmHg at baseline to 14.72 mmHg at one month (a 28.4% reduction) and remained substantially low during the year (15.39 mmHg at six months and 15.44 mmHg at one year). After SLT, the proportion of eyes achieving well-controlled IOP (<21 mmHg) significantly increased from 51.9% at baseline to 96.3% at one year (p < 0.001). This improvement was observed across all patient subgroups, including those with OHT, mild POAG, normal-tension glaucoma, and secondary glaucomas. Before SLT, all patients were medication-free. At one year, 74.1% remained medication-free, while 25.9% required one medication (p < 0.001). Greater IOP reduction was associated with a longer time since SLT, younger age, and diagnoses of mild POAG or normal tension glaucoma (all p < 0.05).

Conclusion: SLT demonstrated significant and sustained IOP reduction in the Saudi Arabian population with OHT and mild POAG. It also led to a substantial decrease in medication use. These findings suggest SLT as a viable primary treatment option for this patient population, though further research is needed to explore long-term outcomes.

References

Mélik Parsadaniantz S, Réaux-le Goazigo A, Sapienza A, Habas C, Baudouin C. Glaucoma: A Degenerative Optic Neuropathy Related to Neuroinflammation? Cells 2020;9:535.

Allison K, Patel D, Alabi O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus 2020;12:e11686.

Noecker RJ. The management of glaucoma and intraocular hypertension: current approaches and recent advances. Ther Clin Risk Manag 2006;2:193–206.

Zgryźniak A, Przeździecka-Dołyk J, Szaliński M, Turno-Kręcicka A. Selective Laser Trabeculoplasty in the Treatment of Ocular Hypertension and Open-Angle Glaucoma: Clinical Review. J Clin Med 2021;10:3307.

Sarenac T, Bečić Turkanović A, Ferme P, Gračner T. A Review of Selective Laser Trabeculoplasty: "The Hype Is Real". J Clin Med 2022;11:3879.

Pahlitzsch, Milena & Davids, Anja-Maria & Winterhalter, et al. (2021). Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First-Step Procedure in Selected Patients with Open-Angle Glaucoma. Ophthalmology and Therapy.

Pillunat KR, Kocket GA, Herber R., et al. Efficacy of selective laser trabeculoplasty on lowering intraocular pressure fluctuations and nocturnal peak intraocular pressure in treated primary open-angle glaucoma patients. Graefes Arch Clin Exp Ophthalmol 2023;261:1979–1985.

Shaw E, Gupta P. Laser Trabeculoplasty 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.

Moore SG, Richter G, Modjtahedi BS. Factors Affecting Glaucoma Medication Adherence and Interventions to Improve Adherence: A Narrative Review. Ophthalmol Ther 2023;12:2863–2880.

Takusagawa HL, Hoguet A, Sit AJ, et al. Selective Laser Trabeculoplasty for the Treatment of Glaucoma: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024;131:37–47.

Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT. Health Technol Assess 2019;23:1–102.

Heng JS, Wormald R, Khaw PT. Geographical variation in glaucoma prescribing trends in England 2008-2012: An observational ecological study. BMJ Open 2016;6:e010429.

Shi JM, Jia SB. Selective laser trabeculoplasty. Int J Ophthalmol 2012;5(6):742–9.

Garg A, Vickerstaff V, Nathwani N, et al. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial. Ophthalmology 2019;126:1238–1248.

Pimentel RL, Alves Júnior RR, Lima WMML, Dantas LOR, Costa VP. Selective laser trabeculoplasty versus micropulse laser trabeculoplasty for intraocular pressure control in patients with primary open angle glaucoma: a 12-month retrospective comparative study. Lasers Med Sci 2023;38:102.

Nagar M, Ogunyomade A, O'Brart DP, et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol 2005;89:1413–1417

Lindén C, Heijl A, Jóhannesson G, Aspberg J, Andersson Geimer S, Bengtsson B. Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study. Acta Ophthalmol 2018;96:567–572.

Latina MA, de Leon JM. Selective laser trabeculoplasty. Ophthalmol Clin North Am 2005;18:409–19.

Funarunart P, Treesit I. Outcome After Selective Laser Trabeculoplasty for Glaucoma Treatment in a Thai Population. Clin Ophthalmol 2021;15:1193–1200.

De Keyser M, De Belder M, De Groot V. Quality of life in glaucoma patients after selective laser trabeculoplasty. Int J Ophthalmol 2017;10:742–748.

Liu D, Chen D, Tan Q, Xia X, Jiang H, Jiang J. Outcome of Selective Laser Trabeculoplasty in Young Patients with Primary Open-Angle Glaucoma and Ocular Hypertension. J Ophthalmol 2020;2020:5742832.

Narayanaswamy A, Sood SR, Thakur S. Selective laser trabeculoplasty: An updated narrative review. Indian Journal of Ophthalmology 2024;72:312–319

Published

2024-12-26

How to Cite

Almarzouki, N. (2024). Outcomes of Selective Laser Trabeculoplasty as Primary Treatment for Ocular Hypertension and Mild Open Angle Glaucoma in the Saudi Arabian Population. Journal of Contemporary Medical Sciences, 10(6). https://doi.org/10.22317/jcms.v10i6.1656